Several lines of evidence point to a compromised proteostasis associated with a reduction of the Ubiquitin Proteasome System (UPS) activity in patients affected by Alzheimer's Disease (AD) and suggest that the amyloid b peptide (Ab) is an important player in the game. Inspired also by many reports, underlining the presence of ubiquitin (Ub) in the amyloid plaques of AD brains, here we set out to test whether Ub may bind the Ab peptide and have any effect on its clearance pathways. By using an integrated array of MALDI-TOF/UPLC-HRMS, fluorescence, NMR, SPR, Microscale Thermophoresis (MST) and molecular dynamics studies, we consistently demonstrated that Ab40 binds Ub with a 1 : 1 stoichiometry and K d in the high micromolar range. In particular, we show that the N-terminal domain of the Ab peptide (through residues D1, E3 and R5) interacts with the C-terminal tail of Ub (involving residues K63 and E64), inducing the central region of Ab (   14   HQKLVFFAEDVGSNK   28 ) to adopt a mixed a-helix/b-turn structure. ELISA assays, carried out in neuroblastoma cell lysates, suggest that Ab competitively binds Ub also in the presence of the entire pool of cytosolic Ub binding proteins. Ub-bound Ab has a lower tendency to aggregate into amyloid-like fibrils and is more slowly degraded by the Insulin Degrading Enzyme (IDE). Finally, we observe that the water soluble fragment Ab1-16 significantly inhibits Ub chain growth reactions. These results evidence how the non-covalent interaction between Ab peptides and Ub may have relevant effects on the regulation of the upstream events of the UPS and pave the way to future in vivo studies addressing the role played by Ab peptide in the malfunction of proteome maintenance occurring in AD.
Introduction
Alzheimer's disease (AD), the most common form of dementia worldwide, is an age-related, fatal neurodegenerative disorder.
A hallmark of AD is the presence of extracellular proteinaceous deposits (senile plaques) in the brain of affected people. The prevalent component of senile plaques is b-amyloid (Ab).
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Although a rm relationship between the occurrence of different Ab aggregates in the AD brain and the severity of the disease has not been established yet, Ab misfolding and selfassembly are widely believed to be crucial pathogenic events in AD (amyloid hypothesis). [2] [3] [4] Unfortunately, all clinical trials of amyloid-targeting drugs have failed so far 5, 6 suggesting that the amyloid hypothesis needs to be reconsidered. Intriguingly, several reports put in evidence that transgenic mice models of AD show an intracellular Ab immunoreactivity 7 which occurs before cognitive loss and massive amyloid plaques deposition and may be more closely associated with the disease progress. 8 Therefore, studies focusing on the interplay between Ab amyloid growth and protein clearance in the cell represent a promising arena for the design of more effective AD therapies. 9 The removal of misfolded and potentially toxic cytosolic proteins is mostly regulated by the ubiquitin proteasome system (UPS). 10 The rst component of the UPS is ubiquitin (Ub), a small protein composed of 76 amino acids, with a compact globular structure characterized by a mixed parallel/ anti-parallel b-sheet packing against an a-helix.
11 Degradation of misfolded proteins by the UPS occurs rst by labeling a lysine residue of the substrate with a (poly)ubiquitin tag (ubiquitinylation) which is specically identied and degraded by the proteasome. 12 When the UPS is not efficient, the removal of toxic protein assemblies gets slower and, in turn, the disease may progress more rapidly.
Consistent with this hypothesis, many reports suggest that the UPS malfunction plays a signicant role in Ab accumulation and, in turn, in AD progress. 13 However, the effects of Ab on proteasome function are still under debate. In particular, on one hand, the Ab peptide has been observed to be a proteasome inhibitor on its own;
14-21 on the other hand some studies have outlined how distinct Ab peptide assemblies may inhibit or even activate different proteasome particles. 22 The controversial role of Ab in affecting proteasome function as well as the presence of Ub-positive proteinaceous aggregates in the senile plaques of AD patients 23 suggests that UPS malfunction observed in AD could be then more likely linked to a failure of its upstream components (i.e., ubiquitinylation).
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Ubiquitinylation needs the coordinated activity of three distinct types of enzyme: (i) an ATP-consuming Ub-activating enzyme (E1); (ii) a Ub-conjugating enzyme (E2) and a Ub ligase (E3). 25 Furthermore, the fact that these processes are largely governed by low-affinity interactions between Ub and the various Ub-writing enzymes (i.e., E1, E2 and E3) 26 envisages the possibility that an excess of Ab might inhibit, as a decoy effect, these processes through non covalent binding to Ub.
To test this hypothesis, here we use a battery of experimental (NMR, SPR, MST, cross-linking XL ESI-MS, MALDI-TOF MS) and in silico (MD) approaches to fully characterize the interactions of Ub with the Ab amyloid peptide in terms of stoichiometry, affinity and binding sites. Next, we employ an ELISA assay to evaluate if the interaction of Ab with Ub is detectable in cell lysates too, thus supporting the signicance of this study in a biological context. These experiments are also paralleled by ESI-MS studies addressing Ab hydrolysis by the Insulin Degrading Enzyme (IDE), a protease which is known to be involved in the physiological amyloid clearance. 27 The effects of Ub on Ab amyloid aggregation and Ub chain growth reactions are nally investigated.
Results and discussion

NMR analysis of Ub in complex with Ab40
In an attempt to assess if Ub binds Ab, we rst analyzed Ub/Ab interactions in solution by NMR spectroscopy. Free 15 N-13 C labeled Ub was characterized by means of a standard set of triple and double resonance experiments that constituted the reference spectra. There are two naturally occurring forms of the Ab peptide: Ab42 and Ab40. Although Ab42 is known to be more prone to form amyloid aggregates, Ab40 is produced more abundantly in the cell (Ab40 : Ab42 molar ratio is 9 : 1) and thus may be more conveniently used to investigate interactions with Ub; 28 furthermore, the tendency of Ab42 to form aggregates makes it very problematic to carry out NMR experiments at very high concentrations. Unlabeled Ab40 was then added as a single aliquot of a known amount to the sample and a new set of spectra was recorded. Fig. S1 in the ESI †). Perturbation of signal intensities with respect to the reference spectra as a function of ligand addition thus provides useful dynamic and conformational information about the binding event. Mapping the differences in normalized signal intensities onto the Ub structure (PDB code: 1UBQ; Fig. 1 upper panel) outlines a region inuenced by the interaction with Ab40, which involves residues belonging to the C-terminal tail and the b sheet of the molecule, leading to a loss in intensity of their HSQC cross-peaks ( Fig. 1 lower panel) . The residues composing the helix appear not to be involved in the interaction as their cross-peaks are less inuenced by the presence of the peptide in solution.
Molecular modeling of Ub/Ab complexes
NMR analysis provides molecular details about the Ub residues directly involved in the interaction with Ab. These data are used as a starting point to describe, at an atomistic level, the Ubbound conformation of Ab by molecular modeling. Upon Ab40 interaction with Ub, three main binding poses may be disclosed ( Fig. 2A) . The rst binding pose features a network of salt-bridges involving the N-terminal section of Ab40, with residues D1, E3 and K28 facing the Ub K6 residue ( Fig. 2A(a) ). This interaction triggers hydrophobic contacts between the Ub central region and Ab40, which mainly adopts turn conformations with a short 3 10 helix involving the 16 KLV 18 segment. At variance with the latter binding surface, in the second binding pose, the N-terminal domain of Ab40 faces the Ub C-terminal region. Herein, Ab40 residues D1, E3 and R5 contact Ub residues K63 and E64, perturbing the typical salt-bridge network featuring the free Ub structure ( Fig. 2A(b) ). The central region of Ab40 is less prone to interact with Ub owing to the intramolecular interactions building an a-helix in the 14 HQKLVFFAEDVGSNK 28 segment. In the third binding pose, the Ab40 charged N-terminal amine of D1 faces residue E64 of Ub ( Fig. 2A(c) ). Even in this binding pose, the salt-bridge between K63 and E64 is affected by the N-terminal amine group. Furthermore, D23 comes in contact with R42 which is close to R72, perturbing the typical network of the charged arginine residues of the Ub structure. The central region of Ab40 is involved in a loop, forming a small b-turn, which involves the segments 16 KL 17 and 35 MV. 36 On the whole, the Ab40 N-terminal domain interacts with both the N-and C-terminal regions of Ub triggering subtle variations in the Ab central domain which folds in a-helical structures resembling those observed elsewhere for membrane-bound Ab peptides. 34 Notably, molecular modeling suggests that the Ub binding induces signicant structural constraints along the region encompassing the hydrophobic Phe residues of Ab.
Cross-linking experiments. Chemical cross-linking/mass spectrometry (XL-MS) is a well-established tool that allows gaining insights into protein conformations and proteinprotein interactions.
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It relies on creating distance constraints between cross-linked amino acid side chains that can be further used to derive protein structures. Cross-linking can involve two residues belonging to a common protein or to different proteins of a supramolecular complex. In this study disuccinimidyl dibutyric urea (DSBU) 39 has been used as homobifunctional cross-linker. Its succinimidyl ester (NHSester) head groups can react with the nucleophilic side chains of Lys, Ser, Thr, and Tyr, and with the N-terminus of proteins xing their spatial arrangement. The cross-linked proteins and protein assemblies can be subsequently studied by mass spectrometry (MS) following a bottom-up approach. Such a process allows to unambiguously identify the cross-linked amino acids, proving their proximity in the native structure of the protein assembly. 40 Cross-linking experiments of Ub in the presence of Ab40 have been performed at pH 8 and DSBU has been employed as a reagent for covalently bridging Lys, N-termini, Ser, Thr, and Tyr, which lie within a Ca-Ca distance range of 27Å. Cross-linked samples were subjected to a proteomic analysis following a bottom-up approach and data were scrutinized with MeroX soware. Several intra-and inter-molecular crosslinks have been identied for the Ub/Ab40 complex. Thirteen unique intramolecular Ub cross-links (Table S1 in ESI †) were mapped onto its X-ray structures (PDB code 1UBQ, 1.8Å resolution).
11 The relevant measured Euclidean Ca-Ca distances measured fall within the range of 6.2 to 20.2Å with an average of 15.3Å and are fully consistent with the known 3D arrangement of Ub. Intra-molecular Ab40 cross-links were not considered for deriving structural information. In fact, it is not possible to distinguish between inter-and intra-molecular cross-links of Ab40 as oligomeric Ab40 aggregates may be present in solution during the cross-linking reaction. Four intermolecular cross-links were found between Ub and Ab40. Interestingly, they exclusively involve the N-terminal region of Ab40. In particular, Ab40 D1 was found to be connected to K48 and K63 of Ub. The other two bridges were found between S8 or Y10 of Ab40 and K48 and K63 of Ub. The targeted residues (S8 or Y10) of Ab40 could not be assigned unambiguously. These cross-links were mapped onto the three 3D structure models of the Ub/Ab40 complex disclosed by theoretical calculations (Fig. 2B) . In all three binding poses the measured Euclidean CaCa distances are <27Å, in agreement with distances that DSBU can connect. Interestingly, the overall surface of Ub predicted to interact with Ab40 is conrmed. However, the cross-links involving K63 partially tunnel the protein chains in pose "a" and can be explained only by a high Ab40 exibility. Conversely, all cross-links are fully consistent with the calculated binding poses "b" and "c" (Fig. 2A) . These results mainly support the proposed binding poses "b" and "c" suggesting a structural organization of the Ub/Ab40 complex where the N-terminal part of Ab40 is in close proximity to the salt-bridge between K63 and E64 in Ub. The binding of Ab42 with Ub disclosed through molecular simulations suggests fewer non-covalent interactions than those detected in the binding of Ab40 with Ub. In particular, the salt-bridge network involving D1, E3 and K28 residues and the K6 residue of Ub is herein replaced by a salt-bridge interaction involving D11 or D7 with K6. Furthermore, the salt-bridge interaction between K63 and E64 of Ub remains unperturbed in the presence of Ab42 and no charged residue of Ab42 appears in contact with R42 or R72 of Ub (see Fig. S2 in the ESI †).
Measurement of dissociation constants (K d ) of the Ab40/Ub complex
The majority of known Ub binding partners are characterized by affinities in the micro-molar range (2 mM < K d <500 mM). 41 Here, to evaluate the binding affinity of Ab to Ub, we performed SPR analysis on immobilized Ab40. Ub solutions were prepared by dissolving the protein in 10 mM PBS (pH 7.4)/Tween 20 (0.05%) and the injections were carried out in a serial conguration for 5 minutes at 20 ml min À1 and 30 ml min
À1
, respectively. Different concentration solutions of Ub (43 mM, 86 mM, 171 mM, 343 mM, and 755 mM) were prepared and aer each injection a regeneration step was achieved using NaCl 2 M/NaOH 10 mM (30 ml min À1 for 3 minutes). The resulting sensograms, obtained aer reference subtraction, were extracted with MP-SPR Navi Data viewer analyzed through the Trace Drawer™ soware and kinetic parameters of the interaction between Ub and Ab were calculated. Panel A of Fig. 3 represents the overlay between experimental curves and tted ones, while in Fig. S3 in the ESI † the tting residual value graph is shown. The tting model adopted was "OneToOne", which describes one monovalent ligand binding to one target. In this case, the following equation can be assumed to describe the biomolecular interactions: Table S4 in the ESI, † where B max represents the maximum signal Fig. 3 panel B) . Next, to rule out any possible bias due to amyloid aggregation, we also analysed Ab [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , a short soluble fragment that is thought to encompass the residues of the amyloid peptide involved in Ub interaction (see Fig. S4 in the ESI †). We found that Ub is able to bind both the molecules with a comparable
À4 M and
Ab competitively binds Ub in whole cell extracts
SPR and MST analysis have demonstrated that Ab binds Ub with a binding affinity which is comparable with that observed for many other Ub binding proteins. 40 Therefore, our next step was to conrm if Ab may competitively bind Ub also in the presence of the complete pool of cellular Ub binding partners. To this aim, we investigated the interaction of Ub with the Ab peptide in the presence of whole cell extracts from previously differentiated SHSY5Y neuroblastoma cells. Enzyme-linked immunosorbent assay (ELISA) is a convenient method widely employed to analyze protein-protein interactions in complex biological mixtures. Here, we employ an ELISA inhibition procedure, using alternatively Ub or Ab40 as the solution binding partner to demonstrate that Ab maintains its ability to bind Ub also in the presence of all natural cytosolic Ub binding partners (Fig. 4) . The Ab peptide binding to the Ub-coated well surface shows an overwhelming increase of the signal over the control. In this case, the presence of cell lysates reduced the Ab40 binding to Ub by about 50%, thus demonstrating that Ub binds Ab, albeit with a reduced signal intensity, and that this interaction is physiologically relevant, since it occurs also in the presence of the complete pool of cellular Ub binding partners. In a second control experiment, Ub binding to the Ab40 peptide immobilized on the well surface of the ELISA plate shows a signicantly increased signal too (Fig. S5 in the ESI †) . As in the previous experiment, the binding is counteracted by the presence of cell lysates thus demonstrating that Ab may competitively binds Ub also in the presence of all cytosolic components.
The proteolytic activity of IDE versus Ab40 is altered by Ub
Once established that Ab may bind Ub in the cytosol, it is important to evaluate how this interaction may interfere with the physiological peptide clearance. The cellular homeostasis of Ab is regulated by several proteases and degrading systems 42 among which IDE gives a particularly important contribution to the clearance of amyloidogenic peptides 43 including Ab, amylin and insulin. [44] [45] [46] [47] Thus, any substance that somehow interacts with Ab under physiological conditions could reasonably affect its IDE-mediated hydrolysis. In this context, the dosedependent effect of Ub on the IDE-catalyzed hydrolysis of Ab has been evaluated through a proteomic approach based on Ultra Performance Liquid Chromatography (UPLC) coupled with High Resolution Mass Spectrometry (HRMS). The enzymatic degradation of the amyloid peptide produced nine peptide fragments within 60 min of reaction (Table S3 in the ESI †). As previously described, 48 in the early stage of the IDEmediated hydrolysis, the main targeted regions encompass the hydrophobic Phe residues, the vicinal His residues, and, to a lesser extent, Asn27 and Met35 (Fig. 5A) . By means of the LC-MS analysis, all complementary peptide fragments adjacent to each cleavage site have been detected. The total amount of the full length substrate (i.e., Ab40) clearly decreases over the reaction time (Fig. 5B) such that aer 20 min of reaction the concentration of Ab40 is 28% relative to the initial value and drops down to 5% aer 30 min. Such a trend is maintained when Ub was added to the reaction mixture but it is noteworthy that the rate of signal decrease is affected by Ub in a dosedependent manner (Fig. 5B) . When the Ub : Ab40 molar ratio is 0.5 : 1, the residual substrate is 32% aer 30 minutes with respect to the starting condition. Finally, 56% of Ab40 is still present aer 60 min of reaction at the highest Ub : Ab40 molar ratio tested (3 : 1). Although the documented interaction between IDE and Ub 49 does not rule out the possibility that Ub itself might somewhat affect IDE proteolytic activity, data shown in Fig. 5 represent a clear evidence in favor of an inhibitory effect by the non-covalent interaction between Ub and Ab40 on the IDE-mediated hydrolysis of Ab40, in accordance with other experimental approaches adopted throughout this paper. In order to elucidate the regions of the Ab sequence mainly involved in the interaction with Ub, the amount of all peptide fragments was reported as a function of the Ub : Ab40 molar ratio (Fig. 5C ). In the absence of Ub (green bars) and in samples collected aer 60 min of reaction, the chromatographic peaks having the higher intensity are those related to the complementary peptides Ab [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] and Ab , whereas Ab 1-20 , Ab [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , Ab and Ab are barely detectable. Increasing amounts of Ub had a very small effect on the concentration of Ab [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and Ab [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] ; only a slight increase was observed for Ab [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , whilst the concentration of Ab , Ab and Ab was greatly affected by the presence of Ub in a dose-dependent manner. In particular, the formation of Ab (and even more of Ab ) is activated by the presence of Ub, whereas the formation of Ab 20-40 is greatly inhibited proportionally to the concentration of Ub. The opposite trend, relative to the amounts of these peptide fragments formed at the various peptide : Ub ratios, is evident in Fig. 5D .
The non-covalent interaction between Ab and Ub has a clear site-specic effect on the IDE-mediated hydrolysis of Ab. The trend related to the formation of peptide fragments indeed suggests that Ub somehow inhibits the cleavage of the Phe19-Phe20 peptide bond. Such an effect of Ub on the degradation pathway of Ab is in accordance with molecular models, described above (see Fig. 2) , showing signicant structural restraints, occurring upon Ub binding, in Ab regions encompassing the central hydrophobic cluster (14-28 residues) . The strong activation of the enzymatic hydrolysis at His13-His14 and His14-Gln15 might be considered a natural consequence of the inhibition involving the vicinal Phe residues. Indeed, Ab and Ab are also processed by IDE to form Ab 20-40 ; therefore, their own Ub-dependent accumulation is reasonably considered a consequence of the effect of Ub on the formation of Ab . It is noteworthy that the crossing point between the Ub-induced increase of Ab and the concomitant decrease of Ab is reached when the Ub : Ab molar ratio is 1 : 1. This evidence indeed strongly supports the 1 : 1 stoichiometry of the Ub : Ab complex evidenced by all other experiments (NMR, XL-MS, SPR, MST and modeling). The 1 : 1 Ub : Ab adduct has also been observed by MALDI-TOF measurements (Fig. 6) . The molecular weight of the 1 : 1 adduct was detected in all samples containing both the amyloid peptide and Ub (Fig. 6, le graph) . Moreover, the higher the Ub : Ab molar ratio, the higher the absolute intensity of the mono-charged peak detected in linear mode, as a direct consequence of the amount of the complex formed. As a further conrmation of the peak attribution, these peaks drop down in the presence of IDE and proportionally to the reaction time, regardless of the Ub : Ab molar ratio (Fig. 6,  right graphs) . This trend can only be ascribed to a Ub-related inhibition of Ab hydrolysis by IDE. These results coupled also with the nding that Ab is a proteasome inhibitor (see Fig. S6 in the ESI †) support the hypothesis that excess Ab may signi-cantly affect protein clearance pathways.
Ub interferes with Ab amyloid growth
It is known that Ab aggregation starts intracellularly, 50 likely during abnormal interactions with lipid membranes. [51] [52] [53] In order to investigate if the interaction between the amyloid peptide and ubiquitin modies the well-known propensity of Ab to aggregate into amyloid-like bers, the amyloid aggregation of Ab was monitored by using a switch-on uorescent dye (ThT). The experimental data obtained by the kinetic measurements were properly tted to the theoretical aggregation models ( Fig. 7 ) in order to calculate the kinetic parameters of the aggregation process (Table S2 in the ESI †). The amyloid-like aggregation of Ab follows a sigmoidal trend, as previously reported. 54 The lag phase of the self-induced aggregation of Ab lasts 19.2 h. Such a value signicantly increases in the presence of Ub, even when the Ub : Ab molar ratio is 0.2 : 1. The lengthening of the lag phase is proportional to the added amount of Ub and t lag becomes more than 60 h when the Ub : Ab molar ratio is 3 : 1. The maximal uorescence gain (F max À F 0 ), proportional to the extent of bril formation, has an opposite trend with respect to the concentration of Ub. The F max À F 0 value is signicantly affected by Ub when the Ub : Ab molar ratio is equal or higher than 0.2 : 1. The F max À F 0 value is 2.2 at the highest ratio tested (3 : 1). These data demonstrate that Ub delays the amyloid-type aggregation of Ab in a dosedependent manner and considerably reduces the extent of the bril formation. Such an effect might be ascribed to a direct or indirect inuence on the Ab sequence covering the LVFF motif, which is involved in the mechanism of the amyloid aggregation and is a common target of many inhibitors of the Ab aggregation. 55 This hypothesis is congruent with the results of the IDEmediated hydrolysis of Ab in the presence of Ub.
Ab 1-16 inhibits Ub chain growth reactions in tube tests
In the cell, Ub chain growth is initiated by the Ub-activating enzyme E1, which adenylates the C-terminus of ubiquitin in an ATP-dependent fashion to form a high energy thioester bond by a cysteine residue. Then, E1 hands the activated Ub over to a conjugating enzyme (E2), forming an E2-Ub complex in proximity of the target protein. The nal ubiquitinylation of the substrate occurs through the action of specic E3 ubiquitin ligases. Unanchored (or free) Ub chains (i.e., Ub chains that are not linked to any substrate) are normally considered very useful tools to study ubiquitinylation processes. A number of protocols have been developed to produce K48 and K63-linked free Ub chains in tube tests, 56 which may be thus considered as a helpful method to single out the capacity of adverse factors in affecting the Ub-conjugation machinery.
56 Due to its signicant affinity for Ub, it is plausible that Ab may interfere with the complex cascade of events leading to poly-ubiquitinylation. To address this issue, we have carried out poly-ubiquitinylation reactions in the presence of increasing concentration of Ab. First, we tried to use the full length Ab40 peptide, but the simultaneous formation of high molecular weight oligomeric species during the ubiquitinylation reactions masked any Table S2 . † possible effect. Then we used a soluble Ab [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] peptide, a fragment that contains all peptide residues that previous experiments consistently identied as Ub binding sites. The Ab [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] peptide has been added with a ratio 1 : 0.5, 1 : 1 and 1 : 2 with respect to Ub to both reaction mixtures (Fig. 8) . Western Blot (WB) analysis has shown the dose-dependent inhibitory effect of the Ab 1-16 peptide on both Lys48-and Lys-63-linked ubiquitin chain elongation, being already evident at a ratio 1 : 1 of Ub/ Ab [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . These data have further demonstrated that the interaction of Ub and Ab hinders the regions close to the lysine 63 and 48.
Conclusions
Although accumulation of extracellular amyloid plaques in the brain is widely considered a hallmark of AD, a direct relationship between amyloid load and cognitive decline has never been unequivocally demonstrated. On the other hand, it is becoming increasingly evident that an abnormal rise of intracellular Ab levels may be better correlated with neuronal loss and disease progression. Unfortunately, our knowledge of the intracellular chemistry of Ab is largely incomplete and there is an urgent need for a more detailed description of the role played by Ab in the pathological failure of cytosolic protein clearance supervisors like UPS and IDE.
Here, we show that Ab has a relatively signicant affinity for Ub. It forms 1 : 1 protein-protein complexes mostly involving the C-terminal tail and the b1/b2 loop of Ub. Next, consistent with many reports showing that Ub is oen recognized by binding proteins through the hydrophobic surface encompassing residues Leu8, Ile44, His 68 and Val 70, 57 non-covalent interactions involving the central hydrophobic cluster of Ab40 and the Ub Ile44 were also observed. The residue D1 of the peptide was found to be linked to the K48 and K63 residues of Ub. These two Ub residues were also found to be in contact with residues S8 and Y10 of Ab40. The N-terminal segment of Ab40 (residues D1 E3 and R5) interacts with the Ub C-terminal domain and in particular with residues Lys63 and Glu64. Consistent with the observation that Lys48 and Lys63 residues are buried upon interaction with the N-terminal domain of Ab, we have also observed that the water soluble fragment Ab [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] signicantly inhibits Ub chain growth in tube tests. It is noteworthy that the Ab/Ub interaction resembles non covalent contacts between Ub and Ub binding domains (UBDs) which are important players in Ub chain growth and signaling. For example, most of the known UBDs are predominantly a-helical and bind the Ile44 hydrophobic patch of Ub. 58 Moreover, most of the UBDs exhibit binding affinities (K d ) in the range between 2 and 500 mM. 41 Next, Ab 40 may assume an a-helical structure in its central hydrophobic cluster (residues 14-20) upon interaction with Ub. Besides these hydrophobic contacts, salt bridges connecting the D1 residue of Ab40 with K63 and K48 of Ub are also evident. This coupled electrostatic/hydrophobic interaction likely explains the evident binding affinity of Ab for Ub and may explain why the peptide is a competitive Ub binding protein. Furthermore, while on one side Ab binding to Ub compromises its ability to recognize physiological binding partners, on the other side it signicantly inuences peptide secondary structure and ability to self-assemble into amyloid-like aggregates and to be degraded by IDE. The reduced propensity of Ab40 to aggregate into amyloid brils is ascribable to the increased ahelical content observed in the Ub-bound peptide. This ability of Ub to mold poorly structured peptides has been already observed in previous reports. 30 Remarkably, Ub/Ab interactions also have a site-specic effect on the IDE-mediated degradation process of the amyloid peptide with possible consequences on the toxicity of the hydrolyzed Ab fragments. 59 Conclusively, these results evidence how the non-covalent interaction between Ab40 and Ub may have important consequences in the regulation of the upstream events of the UPS and in IDEmediated clearance pathways. These results may hopefully pave the way to future studies addressing the multifaceted role played by the altered Ab homeostasis occurring in AD. 
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